0.9251 0.018 (1.96%) | 05-16 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 1.4 ![]() |
1-year : | 1.63 ![]() |
Resists | First : | 1.2 ![]() |
Second : | 1.4 ![]() |
Pivot price | 0.85 ![]() |
|||
Supports | First : | 0.85 ![]() |
Second : | 0.63 ![]() |
MAs | MA(5) : | 0.9 ![]() |
MA(20) : | 0.81 ![]() |
MA(100) : | 0.93 ![]() |
MA(250) : | 1.33 ![]() |
|
MACD | MACD : | 0 ![]() |
Signal : | 0 ![]() |
%K %D | K(14,3) : | 50.9 ![]() |
D(3) : | 49.7 ![]() |
RSI | RSI(14): 57.4 ![]() |
|||
52-week | High : | 3.03 | Low : | 0.56 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ CHEK ] has closed below upper band by 32.0%. Bollinger Bands are 35.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 1.06 - 1.07 | 1.07 - 1.07 |
Low: | 0.84 - 0.84 | 0.84 - 0.85 |
Close: | 0.92 - 0.92 | 0.92 - 0.93 |
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Thu, 01 May 2025
Check-Cap Ltd. Delays Annual Report Filing - TipRanks
Tue, 15 Apr 2025
Check-Cap Faces Nasdaq Compliance Challenge and Announces Key Appointments - TipRanks
Thu, 26 Dec 2024
Check-Cap Ltd. Approves $6M Loan to Nobul AI Corp. for Expansion - TipRanks
Tue, 24 Dec 2024
Why Carbon Revolution Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket - Benzinga
Mon, 25 Mar 2024
Nobul and Check-Cap announce definitive merger agreement - Investing.com
Mon, 08 Jan 2024
symbol__ Stock Quote Price and Forecast - CNN
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Diagnostics & Research
|
|
Shares Out | 6 (M) |
Shares Float | 4 (M) |
Held by Insiders | 25 (%) |
Held by Institutions | 2.3 (%) |
Shares Short | 48 (K) |
Shares Short P.Month | 93 (K) |
EPS | -2.15 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 2.94 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | -33.3 % |
Return on Equity (ttm) | -53.1 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | -2.35 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -14 (M) |
Levered Free Cash Flow | -10 (M) |
PE Ratio | -0.44 |
PEG Ratio | 0 |
Price to Book value | 0.31 |
Price to Sales | 0 |
Price to Cash Flow | -0.39 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |